<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02360722</url>
  </required_header>
  <id_info>
    <org_study_id>BL26</org_study_id>
    <nct_id>NCT02360722</nct_id>
  </id_info>
  <brief_title>Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly</brief_title>
  <official_title>Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single- country, interventional, double-arm study involving Chinese Elderly
      subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to understand the following:

        1. The effect of long-term Oral Nutritional Supplementation (ONS) on improving nutritional
           and health status in Chinese elderly.

        2. The impact of long-term ONS on health cost including both medical cost and social health
           care burdens.

        3. The impact of long-term ONS on life quality of the elderly. The study includes Screening
           Visit (Day -7~0), and Visit 1(Day 0) to Visit 7 (Day 168Â±3). Enrollment of anticipated
           666 subjects, Male or female Chinese ages &gt;= 60 years, to get 400 evaluable subjects.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study was cancelled due to change in food registration regulations in China.
  </why_stopped>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of body weight from baseline to the end of the study</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of sick days due to Upper Respiratory Tract Infections (URTI)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Oral Nutritional Supplement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ONS + Nutritional education</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Nutritional education only</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oral Nutritional Supplement</intervention_name>
    <description>Will receive ONS twice a day for 6 months and two nutritional education at baseline and 3 months after intervention</description>
    <arm_group_label>Oral Nutritional Supplement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nutritional Education</intervention_name>
    <description>Two nutritional education courses at baseline and 3 months after intervention</description>
    <arm_group_label>Oral Nutritional Supplement</arm_group_label>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female Chinese ages &gt;= 60 years.

          2. Subject is ambulatory.

          3. Subject with risks of malnutrition defined as DETERMINE score &gt;=3

          4. Subject's BMI is below 28.

          5. Subject has experienced hospital stay or surgery within 6 months prior to enrollment;

          6. Subject if takes any medications for concomitant chronic diseases should be in stable
             dosage for at least 3 weeks.

          7. Subject plans to live in the community for more than 6 months after recruitment.

          8. Subject has voluntarily signed and dated an informed consent form, approved by an
             Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any
             participation in the study.

        Exclusion Criteria:

          1. Subject has history of allergy to any ingredient in the study product

          2. Subject dislikes the experimental product

          3. Subject has been diagnosed with diabetes.

          4. Subject who has malignancy expected to receive chemotherapy/ radiotherapy scheduled
             during the study period,

          5. Subject has a life expectancy less than 6 months.

          6. Subject who has reported chronic liver disease or liver cirrhosis or liver failure or
             any liver diseases not suitable for the study as the study physician's opinion.

          7. Subject who has reported impacted renal function as eGFR &lt; 30 mL/min/1.73 m2 or renal
             dysfunction severe greater than stage 4 or any other renal diseases not suitable for
             the study as the study physician' s opinion.

          8. Subject who has experienced fever or diarrhea within one week prior to enrollment.

          9. Subject who is expected to have scheduled major surgery during the study period.

         10. Subject who has physical disabilities such as loss of hand or foot or limbs or any
             other physical disability which may affect the muscle mass measurement by the opinion
             of the study physician.

         11. Subject has an implanted electronic device or orthopedic metal implantations, such as
             pacemaker, cardiac defibrillator, subcutaneous injection pump, or metal hip, metal
             knee joint, metal fracture internal fixation, etc.

         12. Subject who has active tuberculosis (TB), hepatitis, or HIV infection as self-reported
             at enrollment.

         13. Subject has severe dementia or delirium, brain metastases, eating disorder, history of
             significant neurological or psychiatric disorder, or other conditions that may
             interfere with study product consumption or compliance with study protocol procedures
             in the opinion of the principal investigator or study physician.

         14. Subject is drug addicted or alcohol addicted

         15. Subject has any other disease or situation who should not to participate in the study
             by the opinion of study physicians.

         16. Subject is participating in other clinical trials which are not approved by AN
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xianfeng ZHAO, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition R&amp;D China</affiliation>
  </overall_official>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2015</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

